AVNS logo

AVNS
Avanos Medical Inc

183
Mkt Cap
$1.16B
Volume
2.73M
52W High
$24.91
52W Low
$9.30
PE Ratio
-15.35
AVNS Fundamentals
Price
$24.65
Prev Close
$24.70
Open
$24.75
50D MA
$19.88
Beta
0.91
Avg. Volume
2.36M
EPS (Annual)
-$1.57
P/B
1.47
Rev/Employee
$306,602.54
$559.25
Loading...
Loading...
News
all
press releases
New Strong Sell Stocks for May 15th
AVNS, BKR and CAG have been added to the Zacks Rank #5 (Strong Sell) List on May 15th, 2026.
News Placeholder
More News
News Placeholder
Deciphering Avanos Medical (AVNS) International Revenue Trends
Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
News Placeholder
AVNS Gains After Posting Q1 Earnings Miss & Revenue Beat, Margins Down
Avanos Medical tops Q1 revenue estimates on strong SNS growth, but margin pressure and PM&R weakness weigh on earnings and profitability.
News Placeholder
Avanos Medical (NYSE:AVNS) Issues Quarterly Earnings Results, Beats Expectations By $0.08 EPS
Avanos Medical (NYSE:AVNS - Get Free Report) posted its earnings results on Tuesday. The company reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of $0.14 by $0.08. Avanos Medical had a negative net margin of 10.40% and a positive return on equity of 5.47...
News Placeholder
Avanos Medical (NYSE:AVNS) Sets New 1-Year High Following Strong Earnings
Avanos Medical (NYSE:AVNS) Reaches New 1-Year High on Strong Earnings...
News Placeholder
Avanos Medical (AVNS) Lags Q1 Earnings Estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of -4.35% and +7.61%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Avanos Medical, Inc. Announces First Quarter 2026 Results
Avanos Medical, Inc. Announces First Quarter 2026 Results Avanos Medical, Inc. Announces First Quarter 2026 Results PR Newswire ALPHARETTA, Ga., May 5, 2026 Delivered double-digit organic growth led...
News Placeholder
InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates
InspireMD (NSPR) delivered earnings and revenue surprises of +15.79% and +25.85%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Avanos Medical (NYSE:AVNS) Sees Unusually-High Trading Volume - Here's Why
Avanos Medical (NYSE:AVNS) Sees Strong Trading Volume - What's Next...
News Placeholder
Top 3 Health Care Stocks That May Collapse This Month
Stocks AVNS, APLS, and CERS in healthcare sector flashing warning to momentum-sensitive investors. High RSI values & price action indicate overbought conditions. AVNS at 90. APLS at 86. CERS at 86...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available